A important advancement in diabetes care is emerging with the introduction of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://jayanalo214606.topbloghub.com/47423062/groundbreaking-development-tirzepatide-45mg-for-diabetes-regulation